Paul Stoffels to bring Galapagos’ cell therapies back to life
Paul Stoffels isn’t giving up on the cell therapy plans he had at Galapagos, the Belgian drug developer that he tried turning around as CEO before abruptly departing last year. Stoffels is behind a new ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.